That is no longer a problem for what is arguably the most complex of these alkaloids, a compound called Serratezomine A: an alkaloid that could have anti-cancer properties and may combat memory loss.
A team of synthetic chemists at Vanderbilt University report in the March 18 issue of the Journal of the American Chemical Society that they have created an efficient way to make this molecule from scratch.
It took six years to develop the process because the researchers had to invent some entirely new chemical methods to complete the synthesis. These methods should make it easier to synthesize other Lycopodium alkaloids as well as other natural compounds with therapeutic potential.
In addition to their therapeutic possibilities, the Vanderbilt chemists were attracted to these compounds because they are among the most intricately structured and functionally dense of all the small molecules produced by living organisms. The compounds consist of carbon and nitrogen atoms assembled in unique ring structures.
"This was a challenging problem," says Professor of Chemistry Jeffrey Johnston, who led the research effort. 'It takes years to develop a new chemical reaction and then apply it to the natural product target. So, once we start, we don't stop."
In the world of total synthesis chemistry, it is not enough to figure out a way to synthesize a naturally occurring molecule. The process has to produce large enough quantities of the molecule that it can be tested for biological activity. That means that the number of sequential steps in the process – what chemists refer to as the longest linear sequence – should be as small as possible to maximize production. For example, if a sequence has 30 steps and each step has an 80 percent yield, the overall yield of the sequence is about one-tenth of a percent. At the same time, one low-yield step will knock a process out of contention.
The longest linear sequence in the Serratezomine A synthesis is 15 steps and it has an overall yield of 1.7 percent, Johnston says. That is an average yield of 77 percent per step. The chemists kept the sequence this short by using a strategy called convergence. They prepared one of the key fragments in the synthesis in parallel to the main sequence.
Johnston has handed over the Serratezomine A that his group has produced to Vanderbilt's drug discovery program, which identifies novel agents suitable for preclinical testing, in order to evaluate its therapeutic value.
Members of Johnston's research team are doctoral student Aroop Chandra; Julie A. Pigza, who is now a post-doctoral associate at the University of California, San Diego; Jeong-Seok Han, who now works at CJ Pharmaceuticals in South Korea; and Daniel Mutnick, who is now an associate scientist at Novartis in San Diego. The research was supported by grants from the National Institute of General Medical Sciences and Eli Lilly and Company and by a Pfizer Diversity Fellowship.
David F. Salisbury | EurekAlert!
During HIV infection, antibody can block B cells from fighting pathogens
14.08.2018 | NIH/National Institute of Allergy and Infectious Diseases
First study on physical properties of giant cancer cells may inform new treatments
14.08.2018 | Brown University
Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.
When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...
Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.
Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....
Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.
Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...
Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur
What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...
The quality of materials often depends on the manufacturing process. In casting and welding, for example, the rate at which melts solidify and the resulting microstructure of the alloy is important. With metallic foams as well, it depends on exactly how the foaming process takes place. To understand these processes fully requires fast sensing capability. The fastest 3D tomographic images to date have now been achieved at the BESSY II X-ray source operated by the Helmholtz-Zentrum Berlin.
Dr. Francisco Garcia-Moreno and his team have designed a turntable that rotates ultra-stably about its axis at a constant rotational speed. This really depends...
08.08.2018 | Event News
27.07.2018 | Event News
25.07.2018 | Event News
14.08.2018 | Information Technology
14.08.2018 | Life Sciences
14.08.2018 | Life Sciences